Medical Cannabis

Dor established a Medical Cannabis Division with the objective of providing professional, high-quality solutions to Israeli medical cannabis companies that focus on shortening the time to market and on strict compliance with the new regulations.

More Industries

EU-GMP Post-Harvest

Regulatory advice in relation to EU-GMP post-harvest – assistance and involvement in the planning, construction, operation and qualification of growers and manufacturers in post-harvest sites, and in compliance with the regulatory requirements in Israel and abroad (IMC-GMP and EU-GMP)

Registrations of medical cannabis products

Registrations of medical cannabis products in Europe, registrations of medical cannabis products in countries that have legalized the sale of medical cannabis products, registrations with the regulatory authorities in Germany, the Czech Republic, Poland, Holland and more.

Packaging materials for medical cannabis products

End-to-End services, including patient leaflets and physician leaflets (SPC), labels and packaging materials for medical cannabis dried flowers, oils, rolls and more. Work opposite the regulatory authority, regulatory preparation and registration, translations to English and Hebrew, graphic design and layouts, proofreading, preparation for printing and full responsibility for printing at pharma grade printshops, which are supervised by the major pharmaceutical companies in Israel.

Regulatory assistance to private/white label medical cannabis companies

Assistance and supervision of shipments of raw materials from farms to local manufacturers, QP services for batch releases, QP pharmacist services for drugs, supervision of the interfaces between farms and manufacturing plants, training, quality agreements (SLAs) and assistance under the working conditions with medical cannabis during the transition between GAP (good agricultural practices) and GMP (good manufacturing practices)